Client News

Imcyse SA: Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round – Pfizer Joins as Newest Shareholder

DEBx Medical publishes first clinical data on novel desiccant gel for chemical debridement of infected, chronic wounds in peer-reviewed journal, Wounds

XPhyto european CE-IVD apllication for 25-minute COVID-19 RT-PCR test

CENTOGENE GmbH: CENTOGENEs Walk-In-Corona-Testzentrum in Rostock zieht in die Innenstadt und erweitert Fläche, Angebot und Öffnungszeiten

Rentschler Biopharma SE: Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

Rentschler Biopharma SE: Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

XPhyto adds Mescaline production to psychedelic medicine programs

MagForce AG: MagForce USA, Inc. Announces Completion of Patient Treatment in Stage 2a of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

Secarna Pharmaceuticals: Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director

Imcyse SA: Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis